Applied Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLT and other ETFs, options, and stocks.

About APLT

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications.

CEO

Shoshana Shendelman

CEOShoshana Shendelman

Employees

Employees34

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2016

Founded2016

Employees

Employees34

APLT Key Statistics

Market cap

53.83M

Market cap53.83M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

449.76K

Average volume449.76K

High today

—

High today—

Low today

—

Low today—

Open price

$0.94

Open price$0.94

Volume

0.00

Volume0.00

52 Week high

$11.47

52 Week high$11.47

52 Week low

$0.4995

52 Week low$0.4995

APLT Earnings

-$1.25

-$0.83

-$0.42

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 9, Pre-Market

ActualExpected Mar 9, Pre-Market

Applied Therapeutics

Why Robinhood?

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. Show more

APLT Key Statistics

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications.